Table 4.
Multivariable adjusted hazard ratio (HR) with 95 % confidence limits (CI) for the dose of iron supplements and the risk of total mortality in women aged 55–69 years at baseline from the IOWA Women’s Health Study
Dose of iron supplement (mg d–1) | Cases | HR xx | Cases | HR (95 % CI) | Cases | HR (95 % CI) | Cases | HR (95 % CI) | Cases | HR (95 % CI) |
---|---|---|---|---|---|---|---|---|---|---|
Non-users | > 0–50 | > 50–200 | > 200–400 | > 400 | ||||||
Follow-up period | ||||||||||
1986–2008 | 13 801 | 1 | 527 | 1.02 (0.93–1.12) | 222 | 1.08 (0.94–1.24) | 118 | 1.35 (1.12–1.63) | 47 | 1.57 (1.17–2.11) |
1986–1996 | 3675 | 1 | 144 | 1.09 (0.92–1.30) | 59 | 1.12 (0.86–1.46) | 37 | 1.41 (1.01–1.96) | 16 | 1.70 (1.02–2.83) |
1997–2003 | 2943 | 1 | 115 | 1.13 (0.92–1.39) | 74 | 1.69 (1.33–2.14) | 59 | 1.30 (0.97–1.74) | 14 | 1.91 (1.06–3.45) |
2004–2008 | 1913 | 1 | 71 | 1.66 (1.28–2.14) | 71 | 1.85 (1.43–2.39) | 58 | 1.67 (1.25–2.22) | 17 | 2.01 (1.19–3.40) |